Cross-disciplinary skills

New

Level 2 -

How to successfully negotiate your license?

Presentation

Why participate?
Gain a clear understanding of the stakes involved in licensing in order to negotiate your license under the best possible conditions, whether you are the licensor or the licensee.

Training context
Taking the step into licensing allows the licensor to generate revenue by entering new markets and accelerating the business development of their company, while the licensee can enhance their innovation strategy based on already mature research and development. This is why a licensing agreement can be particularly advantageous—provided that its terms are negotiated properly to ensure the success of the partnership between the parties, while also respecting their respective needs.

Learning objectives

  • Understand the licensing objectives for each party
  • Anticipate the critical points of a licensing negotiation
  • Understand how each party will try to protect its interests
  • Explore solutions for a successful negotiation

Teaching methods

Interactive Teaching, Case Studies, Experience Sharing

Audience

The training is intended for business leaders, project managers, researchers, engineers, or anyone involved in strategic licensing decisions (including both out-licensing and in-licensing), particularly when participating in negotiations.

Prerequisites

No prerequisites required

Duration

Half-day, 3.5 hours

Price

300 € HT (Académique)
375 € HT (Public)
150 € HT (Académique)

Prices: Excluding tax, as the training is not subject to VAT.
In-house training rate: Please contact us.

Sessions

No session available

Trainers

Catalogue de formations-MabDesign-2023.pdf (21)

Mathilde

SALAVIN

Partner lawyer
MCE Carrel

Rating

There is no rating available because this training session was never carried out.

The benefits of our courses

  • Personalized support
  • Practical advice – Feedback from experience
  • Educational materials provided to participants
  • Skills assessment
  • Certificate of completion
  • Training quality evaluation
  • Accessible to people with disabilities (please contact us)

How to access and deadlines

Registering online or by e-mail is a pre-registration. We will process your request within one week:

  • Contact by e-mail or telephone
  • Sending of administrative and educational documents: training agreement, training programme and positioning questionnaire.

Signing the training agreement commits the company or individual to the training course. Cancellation conditions are specified in the training agreement.

When no session date is specified, pre-registration allows us to note your interest in a programme, and we will keep you informed as soon as a new session is organised.

For more information, contact Daphné Brisard: 02 47 36 63 18 or formation@mabdesign.fr

Jean-Roch Fabreguettes

MEARY

Directeur Médical et Personne Responsable du Centre MEARY de thérapie cellulaire et génique au sein de l’hôpital Saint-Louis à Paris

Jean-Roch Fabreguettes est un spécialiste de la recherche translationnelle et des phases précoces de développement clinique des médicaments de thérapie innovantes (MTI). Pharmacien, titulaire d’un doctorat de l’Université de Montpellier 1, il a travaillé plus de 25 ans dans le domaine et a contribué, pour des équipes académiques comme pour des start-ups, à la réalisation de plus de 30 programmes de recherche sur différents types de MTI : thérapie génique in vivo ou ex vivo, thérapie cellulaire, ingénierie tissulaire… Il est actuellement Directeur Médical et Personne Responsable du Centre MEARY de thérapie cellulaire et génique au sein de l’hôpital Saint-Louis à Paris. Le centre MEARY est une plateforme de l’Assistance Publique – Hôpitaux de Paris (AP-HP), dédiée à la fabrication de médicament de thérapie innovante expérimentaux. Laboratoire membre de l’ISCT, il est autorisé par l’ANSM et dispose d’un certificat GMP. A ce titre Jean-Roch Fabreguettes est impliqué dans le développement clinique et la fabrication de nombreux MTI : CAR-T cells, lymphocytes T régulateurs, cellules stromales mésenchymateuses…

Précédemment, Jean-Roch Fabreguettes a été expert Qualité (CMC) auprès de l’ANSM durant 9 ans et a conseillé différentes sociétés de biotechnologies. Il est un intervenant régulier pour l’Université Paris Cité et un membre actif de l’ISCT et de réseaux nationaux et internationaux sur les MTI (UNI-TC, Join4ATMP).